Skip to main content
logo
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.980
-0.005 (-0.25%)
At close: Sep 2, 2026, 4:00 PM EDT
1.990
+0.010 (0.51%)
Pre-market: Sep 3, 2026, 9:13 AM EDT

Allogene Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-165.49-190.89-257.59-327.27-340.41-182.05
Depreciation & Amortization
11.6712.3613.6414.214.310.45
Asset Writedown & Restructuring Costs
-2.3815.7213.25--
Loss (Gain) From Sale of Investments
-3.94-4.22-6.390.192.896.96
Loss (Gain) on Equity Investments
--1.6910.6712.884.09
Stock-Based Compensation
37.4937.6451.7465.9583.680.82
Other Operating Activities
-0.414.365.696.582.33-73.13
Change in Accounts Payable
1.22-1.23-0.5-7.54.87-0.77
Change in Unearned Revenue
-----0.02-38.3
Change in Other Net Operating Assets
17.27-9.65-24.3-13.81-0.957.12
Operating Cash Flow
-102.2-149.25-200.3-237.73-220.52-184.81
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.4-0.39-0.69-1.52-5.19-21.45
Investment in Securities
-131.295.9576.38164.81111.35185.1
Investing Cash Flow
-131.695.5675.69163.29106.16163.66

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
220.0923.25114.495.72.9511.96
Other Financing Activities
-6.912.28---
Financing Cash Flow
220.0930.16116.6895.72.9511.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-13.71-23.53-7.9421.25-111.41-9.19

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-102.6-149.63-200.99-239.25-225.71-206.26
Free Cash Flow Growth
------
Free Cash Flow Margin
-2211.16%--913609.09%-251841.05%-144685.90%-180.79%
Free Cash Flow Per Share
-0.40-0.68-1.03-1.52-1.58-1.52
Levered Free Cash Flow
-63.46-80.73-99.13-134.26-111.74-85.97
Unlevered Free Cash Flow
-62.65-80.06-99.02-134.26-111.74-85.97

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
18.49-10.88-24.8-21.313.9-31.95
SEC Filings: 10-K · 10-Q